IGF2: the Achilles' heel of p53-deficiency?

EMBO Mol Med

Laboratory for Molecular Cancer Biology, Center for the Biology of Disease, VIB-KULeuven, Leuven, Belgium.

Published: August 2012

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494069PMC
http://dx.doi.org/10.1002/emmm.201201509DOI Listing

Publication Analysis

Top Keywords

igf2 achilles'
4
achilles' heel
4
heel p53-deficiency?
4
igf2
1
heel
1
p53-deficiency?
1

Similar Publications

Physical activity increases the risk of non-contact injuries, mainly affecting muscles, tendons, and ligaments. Genetic factors are recognized as contributing to susceptibility to different types of soft tissue injuries, making this broad condition a complicated multifactorial entity. Understanding genetic predisposition seems to offer the potential for personalized injury prevention and improved recovery strategies.

View Article and Find Full Text PDF

Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells.

Oncogene

March 2017

Division of Molecular Therapy, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo, Japan.

The transcription factor nuclear factor-κB (NF-κB) has important roles for tumorigenesis, but how it regulates cancer stem cells (CSCs) remains largely unclear. We identified insulin-like growth factor 2 (IGF2) is a key target of NF-κB activated by HER2/HER3 signaling to form tumor spheres in breast cancer cells. The IGF2 receptor, IGF1 R, was expressed at high levels in CSC-enriched populations in primary breast cancer cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!